WHITEHAWK THERAPEUTICS INC (WHWK) Earnings History & Surprises

NASDAQ:WHWKUS00032Q1040

Current stock price

3.59 USD
-0.22 (-5.77%)
At close:
3.59 USD
0 (0%)
After Hours:

WHWK Earnings overview

Past quarterly earnings results for WHITEHAWK THERAPEUTICS INC (WHWK), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.07
Revenue Estimate

Last Reported

Most Recent
Release Date
Mar 12, 2026
Period
Q4 / 2025
EPS Reported
-$0.34
EPS Surprise
-116.45%
Revenue Surprise
-100.00%

Beat Rate

Last 8 Quarters
25%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.34 -0.16 -116.45% 49.25% 20.4M -100.00% -100.00%
Q3 2025 -0.26 0.07 -482.33% 43.48% 34M -100.00% -100.00%
Q2 2025 -0.76 0.50 -251.03% -40.74% 34M -100.00% -100.00%
Q1 2025 -0.37 -0.47 21.14% 45.59% 7.145M - 33.48%
Q4 2024 -0.67 -0.22 -198.57% -11.67% 7.239M 7.599M -4.74% 14.43%
Q3 2024 -0.46 -0.47 1.43% 23.33% 7.212M 6.728M 7.19% 21.01%
Q2 2024 -0.54 -0.70 23.27% 19.40% 6.179M 6.321M -2.25% -0.34%
Q1 2024 -0.68 -0.66 -3.76% -19.30% 5.353M 6.583M -18.68% -8.81%
Q4 2023 -0.60 -0.66 9.22% -15.38% 6.326M 6.418M -1.43% 20.96%
Q3 2023 -0.60 -0.74 18.75% 11.76% 5.96M 6.745M -11.64% 40.24%
Q2 2023 -0.67 -0.63 -5.60% 22.99% 6.2M 6.325M -1.98% 80.23%
Q1 2023 -0.57 -0.60 4.31% 13.64% 5.87M 5.59M 5.01% 154.11%
Q4 2022 -0.52 -0.72 28.20% 32.47% 5.23M 4.743M 10.27% 423.00%
Q3 2022 -0.68 -0.76 10.15% 50.00% 4.25M 3.846M 10.50% -
Q2 2022 -0.87 -0.77 -13.73% 35.56% 3.44M 2.808M 22.51% 2,766.67%
Q1 2022 -0.66 -0.73 9.12% 51.11% 2.31M 511.02K 352.04% -
Q4 2021 -0.77 -1.00 23.13% 48.67% 1M 45.9K 2,078.65% -
Q3 2021 -1.36 -0.68 -101.01% 24.44% 66.3K -100.00% -100.00%
Q2 2021 -1.35 -6.12 77.94% - 120K - -40.00%
Q1 2021 -1.35 -1.38 1.96% - - -
Q4 2020 -1.50 -2.07 27.38% - - -
Q3 2020 -1.80 -2.14 15.97% - 230K - -
Q2 2020 - - 200K - -
Q1 2020 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

WHWK EPS Q2Q GrowthWHWK EPS Q2Q GrowthEPS Q2Q Growth Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 20 -20 40 -40 60 80

Revenue Historical Q2Q growth and Acceleration

WHWK Revenue Q2Q GrowthWHWK Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q3/21 Q2/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 0 500 1K 1.5K 2K 2.5K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
1
Average EPS beat (4)
-227.70%
Max EPS beat (4)
21.14%
Min EPS beat (4)
-482.33%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, WHWK has beaten EPS estimates in 1 out of 4 releases
In the last 4 quarters, WHWK reported -227.7% below the EPS estimates on average.

WHITEHAWK THERAPEUTICS INC / WHWK Earnings FAQ

What is the most recent earnings date for WHWK stock?

WHITEHAWK THERAPEUTICS INC (WHWK) last reported earnings on 3/12/2026.

Did WHITEHAWK THERAPEUTICS INC (WHWK) beat earnings estimates last quarter?

WHITEHAWK THERAPEUTICS INC (WHWK) missed EPS estimates and missed revenue estimates in the most recent quarter.

How often does WHITEHAWK THERAPEUTICS INC (WHWK) beat earnings estimates?

In the last 4 quarters, WHITEHAWK THERAPEUTICS INC (WHWK) has beaten EPS estimates in 1 out of 4 releases.